Home » FDA Partially Grants Petition on Generic Opioid Testing

FDA Partially Grants Petition on Generic Opioid Testing

April 5, 2017

Pharmaceuticals Quality

The FDA partially granted a petition filed on behalf of Purdue Pharma concerning generic versions of an extended-release opioid.

To View This Article:

Login

24Sep
Domestic Inspections and Risk Assessment: What’s the Same and What’s Different with the FDA’s Resumed Operations?
29Sep
Permitted Daily Exposure/Acceptable Daily Exposure Values: The New Acceptance Criteria in Cleaning Validation
30Sep
POCs, IVDs and LDTs — Way More than Alphabet Soup: What Medical Device Professionals Need to Know for Premarket Approval
07Oct
17th Annual Medical Device Quality vCongress
15Oct
Reliability for Medical Devices: What It Is, How to Analyze It, Make It Work for You
21Oct
FDA’s Plan for Modernizing the 510(k) Pathway: What Regulatory, Quality & Compliance Professionals Need to Know

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements